Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

CASSS Bioassays 2020 Virtual Booth

May 13 - June 30, 2020

Welcome to our virtual booth page for CASSS Bioassays 2020, where you can keep up with the latest information on our functional bioassays for biologic drug discovery. Explore all the highlights that you would have seen from the real Promega booth!

Showcase Presentation

Jey Cheng, Sr. Research Scientist, introduces our portfolio expansion into primary cell-based assays for immunotherapeutic drug development.

You can also review a PDF copy of the presentation.

Download PDF

Poster Presentations

These videos provide a walkthrough of each poster presented at CASSS Bioassays 2020 and related shows. You can also download a PDF version to review later. 


Novel Bioluminescent Bioassays for the Discovery and Development of Molecular and Cellular T-Cell Redirecting Cancer Therapy

Presented by Jey Cheng, Sr. Research Scientist

Download PDF

Richard Moravec

Reproducible, MoA-reflecting Reporter-Based Bioassays to Enable Drug Development of Biosimilars and Biobetters

Presented by Richard Moravec, Sr. Research Scientist

Download PDF


Developing a Bioluminescent PBMC ADCC Assay for the Discovery and Characterization of Therapeutic Antibodies

Presented by Jey Cheng, Sr. Research Scientist

Download PDF


Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors

Presented by Jamison Grailer, Sr. Research Scientist

Download PDF

New Products

Lumit™ Immunoassays

Replace conventional immunoassays, such as Western blots and ELISAs, with new Lumit™ Immunoassays. These assays offer direct luminescence measurement in cell culture, broad dynamic range, and can be completed in as little as 30 minutes.

Lumit™ Immunoassays are available for a range of applications, including protein phosphorylation and pathway analysis, FcRn binding, cytokine detection, metabolite research, and more. You can also build your own Lumit™ immunoassays with our labeling and detection kits.

Learn More

Lumit immunoassay principle

General principle of a Lumit™ Immunoassay. Antibodies are chemically labeled with the small and large subunits of NanoLuc® Luciferase, known as SmBiT and LgBiT, respectively. In the presence of an analyte, the two antibodies come into close proximity, allowing SmBiT and LgBiT to form an active enzyme and generate a bright luminescence signal.


Rapid Antibody Selection Methods for Immunotherapeutic Candidate Development

Selecting the best antibodies against targets of interest can prove challenging for immunotherapy biologic development. In this webinar, Single Cell Technology discusses the AbTheneum™ platform for downstream testing of candidate therapeutic antibodies. By sequencing many single cells simultaneously, the AbTheneum™ platform yields a large number of paired VH and VL sequences, providing a wider pool of options to test and ensuring that valuable antibodies are not excluded.

Date: Wednesday, June 3, 2020

Time: 11:00 am CDT (12:00 pm EDT)

Register Now

Interested in more information about functional bioassays?

View Products